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ABSTRACT
Glucocorticoids (GCs) play essential roles in physiology, development, and behavior that
are mediated largely by the glucocorticoid receptor (GR). Although the GR has been inten-
sively studied in mammals, very little is known about the GR in nonmammalian tetrapods.
We analyzed the distribution and GC regulation of GR in the brain of the frog Xenopus laevis
by immunohistochemistry. GR-immunoreactive (GR-ir) cells were widely distributed, with
the highest densities in the medial pallium (mp; homolog of the mammalian hippocampus),
accumbens, anterior preoptic area (POA; homolog of the mammalian paraventricular nu-
cleus), Purkinje cell layer of the cerebellum, and rostral anterior pituitary gland (location of
corticotropes). Lower but distinct GR-ir was observed in the internal granule cell layer of the
olfactory bulbs, dorsal and lateral pallium, striatum, various subfields of the amygdala, bed
nucleus of the stria terminalis (BNST), optic tectum, various tegmental nuclei, locus coer-
uleus, raphe nuclei, reticular nuclei, and the nuclei of the trigeminal motor nerves. Treat-
ment with corticosterone (CORT) for 4 days significantly decreased GR-ir in the POA, mp,
medial amygdala (MeA), BNST, and rostral pars distalis. Treatment with the corticosteroid
synthesis inhibitor metyrapone (MTP) also significantly reduced GR-ir in the POA, mp, MeA
and BNST, but not in the rostral pars distalis. Replacement with a low dose of CORT in
MTP-treated animals reversed these effects in brain. Thus, chronic increase or decrease in
circulating corticosteroids reduces GR-ir in regions of the frog brain. Our results show that
the central distribution of GR-ir and regulation by corticosteroids are highly conserved
among vertebrates. J. Comp. Neurol. 508:967–982, 2008. © 2008 Wiley-Liss, Inc.
Indexing terms: glucocorticoid receptor; Xenopus; stress response; hypothalamus; limbic system;
hippocampus; amygdala; pituitary
Glucocorticoids (GCs) exert diverse developmental,
physiological, and behavioral actions in vertebrates
(Chrousos, 1998; Chrousos and Gold, 1992). The produc-
tion of GCs by cells of the adrenal cortex (interrenal
glands in nonmammalian species) is controlled by pitu-
itary adrenocorticotropic hormone (ACTH), whose synthe-
sis and secretion is controlled by hypothalamic
corticotropin-releasing factor (CRF) and arginine vaso-
pressin (AVP). Circulating GC concentration increases
rapidly following exposure to stressors, which serves to
coordinate physiological and behavioral adjustments to
maintain homeostasis. Elevated circulating GC concentra-
tion exerts negative feedback at multiple levels of the
hypothalamo-pituitary-adrenal (HPA) axis to prevent con-
tinued activation (Makino et al., 2002a).
The actions of GCs are mediated by two ligand-activated
transcription factors that were originally identified in
mammals based on their differential binding affinities:
the high-affinity type I receptor (also called the “mineralo-
corticoid receptor”; MR; NR3C2) and the lower-affinity
type II receptor (also called the “glucocorticoid receptor”;
GR; NR3C1). The GR and MR belong to the nuclear hor-
mone receptor superfamily, and phylogenetic analysis
suggests that these two receptors arose by a gene dupli-
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cation event in the gnathastome lineage (Bridgham et al.,
2006; Thornton, 2001). In mammals, the MR is hypothe-
sized to function in the maintenance of basal expression
and the circadian rhythm of circulating GCs, whereas
most GC-dependent physiological changes that occur in
response to stressors, and feedback regulation by GCs is
thought to be mediated by the GR (Bamberger et al., 1996;
De Kloet et al., 1998; Wei et al., 2004). In the absence of
ligand, the GR is located in the cytosol associated with
heat shock proteins and immunophilins (referred to as the
“foldosome”; Pratt and Toft, 1997). Ligand binding causes
disassociation of the protein complex and translocation of
GR into the nucleus, where GR regulates transcription of
its target genes (Kumar and Thompson, 2005).
Full-length or partial cDNA sequences for the GR have
been isolated from nonmammalian species, including
birds (chicken, Kwok et al., 2007; zebra finch Taeniopygia
guttata, Hodgson et al., 2007), fishes (the rainbow trout
Onchorhynchus mykiss, Ducouret et al., 1995; tilapia
Oreochromis mossambicus, Tagawa et al., 1997; Japanese
flounder, Tokuda et al., 1999; fathead minnow Pimephales
promelas, Filby and Tyler, 2007), and frog Xenopus laevis,
Gao et al., 1994), and are highly conserved. These genes
were isolated and named based on their sequence similar-
ity to the mammalian GR (Gao et al., 1994; Thornton,
2001). The primary amino acid sequences of the DNA
binding domains of X. laevis and human GR are identical,
and the hormone binding domains share 86% similarity.
The N-terminal domains of frog and mammalian GR pro-
teins are less well conserved, sharing 51% similarity at
the amino acid level (Gao et al., 1994). The X. laevis GR
(xGR), when expressed in COS cells, was capable of me-
diating hormone-dependent transactivation of a GRE-
containing promoter to an extent similar to that of the rat
GR (Gao et al., 1994). These data suggest that the struc-
ture and function of GR are evolutionarily conserved
among vertebrate species.
GR receptor protein and mRNA are widely distributed
in the central nervous system (CNS) of rodents (Ahima
and Harlan, 1990; Morimoto et al., 1996). The highest
levels of GR immunoreactivity (GR-ir) and mRNA were
found in the cerebral cortex, olfactory pyramidal layers,
hippocampal formation, paraventricular nucleus (PVN),
medial and central nuclei of the amygdala, granule layer
of the cerebellar cortex, and locus coeruleus (Ahima and
Harlan, 1990; Morimoto et al., 1996). The hippocampus
expresses the highest level of GR in the mammal brain,
and GC actions here lead to tonic inhibition of neurose-
cretory neurons in the PVN via descending inhibitory
projections to down-regulate the activity of the HPA axis
(Herman et al., 2005). The PVN neurons also express a
high level of GR and thus are direct targets for circulating
GCs (Makino et al., 2002a). GCs influence cognition via
actions on the hippocampus and amygdala (Lupien and
McEwen, 1997; Sapolsky, 2003).
Relatively little is known about the central distribution
of GR in nonmammalian species. To our knowledge, noth-
ing is known about GR distribution in amphibians or
reptiles. Except for one report on GR-like immunoreactiv-
ity in the Japanese quail (Kovács et al., 1989), studies on
the central distribution of GR in nonmammalian verte-
brates have been conducted with teleost fishes. In the
rainbow trout (Oncorhynchus mykiss), among the brain
regions where GR-ir was observed, the highest densities
were found in the ventral telencephalon, preoptic region,
mediobasal hypothalamus, and optic tectum (Teitsma et
al., 1998). Lower densities of GR were seen in the internal
cell layer of the olfactory bulb and lateral regions of the
dorsal telencephalon (Teitsma et al., 1998; see also Car-
ruth et al., 2000, for a study in kokanee salmon). The
generally conserved central distribution of GR in fishes
and mammals suggests that expression and function of
GR in the CNS arose early in vertebrate evolution and
may be conserved.
In an effort to understand the evolutionary origins of
GC targets in the CNS, and the roles of GCs in develop-
ment, physiology, and behavior in extant species, we an-
alyzed the distribution of GR-ir and GR regulation by GCs
in the brain and pituitary gland of the frog X. laevis, an
important model organism in endocrinology and develop-
mental biology. We found that the pattern of GR-ir distri-
bution in the frog brain and pituitary gland is highly
conserved with mammals and fishes. We provide the first
detailed map of GR-ir distribution in the CNS of a non-
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mammalian tetrapod and show that GR expression in the
frog is modulated by GCs, as it is in mammals, suggesting
that this pathway for regulation of the HPA axis is an
ancient and conserved character of the vertebrate lineage.
MATERIALS AND METHODS
Animal husbandry
Xenopus laevis juvenile and adult frogs were purchased
from Xenopus I (Dexter, MI). Frogs were maintained in
the laboratory in well water (20–22°C) under a 12L:12D
photoperiod and fed beef liver. All procedures involving
animals were conducted in accordance with the guidelines
of the University Committee on the Care and Use of An-
imals of the University of Michigan.
Production and purification of polyclonal
antiserum to X. laevis GR
We generated a polyclonal antiserum to the A/B region
of X. laevis GR in rabbit (Lampire Biological, Downing-
town, PA) using a synthetic peptide corresponding to
amino acids 8–25 of xGR (KPSSGSPAVRGSPHYNDK)
conjugated to keyhole limpet hemocyanin. We used an
online computer program available through the Harvard
University Cancer Vaccine Center (http://bio.dfci.-
harvard.edu/Tools/antigenic.pl) to identify antigenic re-
gions of the full-length frog GR protein. The length and
sequence of the N-terminal A/B regions are highly vari-
able among nuclear hormone receptors (Germain et al.,
2006), and the peptide sequence that we chose shows no
sequence similarity to other known frog steroid hormone
receptors (analyzed by alignment of amino acid sequences
of X. laevis mineralocorticoid, androgen, estrogen, proges-
terone, and thyroid hormone receptors using the AlignX
module of the Vector NTI Suite software program; Invitro-
gen, Carlsbad, CA). BLAST search of the NCBI database
showed no sequence similarity of the xGR peptide se-
quence to other known proteins. We purified the anti-
serum over an Affi-Gel Protein A column, followed by
affinity purification over a peptide affinity column with
the xGR antigenic peptide conjugated to Ultralink io-
doacetyl matrix (Pierce, Rockfold, IL), following the man-
ufacturer’s instructions. The concentration of the purified
IgG was determined by the BCA Protein Assay (Pierce).
Western blotting analysis
We conducted Western blotting analysis using in vitro-
synthesized xGR protein or whole-cell extract of XTC-2
cells (X. laevis carcass cell; Pudney et al., 1973). We pro-
duced xGR protein using the p6xGR vector (Gao et al.,
1994) and the TNT system (Promega, Madison, WI), fol-
lowing the manufacturer’s protocols. We included [35S]me-
thionine  cysteine (EasyTag EXPRESS35S protein label-
ing mix; Perkin Elmer, Waltham, MA) in the in vitro
transcription-translation reaction, which we then ana-
lyzed by10% sodium dodecyl sulfate (SDS)-polyacrylamide
gel electrophoresis (PAGE), followed by fluorography. Af-
ter running, the gel was fixed, impregnated with Enhance
autoradiography enhancer (Perkin Elmer), dried, and ex-
posed to X-ray film.
Protein samples were boiled in SDS sample buffer (con-
taining 0.5% SDS, 0.15 mM Tris base, 2.5% glycerol, and
0.0125% bromophenol blue; pH 6.8) for 5 minutes, then
separated on a 10% SDS-polyacrylamide gel. The proteins
were electophoretically transferred to nitrocellulose mem-
branes (Trans-Blot Transfer Medium; Bio-Rad, Hercules,
CA) using a Trans-Blot SD transfer cell (Bio-Rad). Mem-
branes were blocked in phosphate-buffered saline (PBS)
with 0.05% Tween-20 (PBST; pH 7.4), 5% bovine serum
albumin (BSA; Sigma, St. Louis, MO), and 10% normal
goat serum overnight at 4°C, then incubated with affinity-
purified rabbit anti-xGR IgG (0.5 g/ml in PBST with 5%
BSA) overnight at 4°C. After washes in PBST, immunopo-
sitive bands were visualized using the ECL Western blot-
ting system (Amersham, GE Healthcare, Buckingham-
shire, United Kingdom).
Cell culture and GC treatment
Monolayer cultures of the X. laevis kidney cell line A6
were maintained in Leibovitz’s L15 medium (Invitrogen;
diluted 1:1.5 for amphibian cells, pH 7.4) supplemented
with 10% steroid hormone-stripped fetal bovine serum
(Life Technologies, Grand Island, NY) and antibiotics. Ste-
roid hormone removal from fetal bovine serum was con-
ducted by mixing 25 ml serum with 50 mg charcoal [coated
with 5 mg Dextran T 70 (Pharmarcia Biotech, Uppsala,
Sweden) in PBS, pH 7.4] and shaking at room tempera-
ture for 5 hours, followed by centrifugation at 1,000g for
10 minutes. The supernatant was mixed again with 50 mg
charcoal-Dextran and shaken at room temperature over-
night before a final centrifugation at 30,000g for 20 min-
utes at 4°C.
The A6 cells were plated on glass slides and cultured
under a humidified atmosphere of 5% CO2 at 25°C. Cells
were incubated with 100 nM dexamethasone (Sigma), 100
nM corticosterone (Sigma), or vehicle (0.001% ethanol) in
growth medium for 1.5 hours. Then, cells were fixed in 4%
paraformaldehyde and processed for immunohistochemi-
cal analysis of GR (see below).
Immunohistochemistry
We used immunohistochemistry (IHC), following meth-
ods described previously (Yao et al., 2004), to analyze the
distribution of GR-ir in the X. laevis brain. Single IHC for
GR-ir was conducted using the Vectastain Elite ABC (rab-
bit) and Vector VIP kits, following the manufacturer’s
instructions (both from Vector, Burlingame, CA; 0.5 g/ml
affinity-purified polyclonal rabbit anti-xGR IgG). The
specificity of the affinity-purified anti-xGR IgG was tested
by preabsorption with the antigenic xGR peptide or with
unrelated peptides corresponding to three regions of the
frog MR. The MR peptides used corresponded to amino
acid positions 6–45, 32–49, and 160–177 of the X. laevis
MR protein and share no sequence similarity with the
antigenic xGR peptide. The antibodies were incubated
with peptides (10 ng/l) overnight at 4°C before IHC.
Micrographic images were captured using an Olympus
IX81 inverted microscope and a Retiga 1300R fast digital
video camera. Brightness, contrast, and evenness of illu-
mination were adjusted uniformly for images shown in the
figures in Adobe Photoshop CS2; images used for morpho-
metric analysis (see below) were not adjusted.
Corticosterone and metyrapone treatment of juve-
nile X. laevis. For each treatment group, six juvenile
frogs (20–31 g BW) were placed into 30  20  20 cm
tanks containing 5 liters of water, and the tanks were
shielded to minimize disturbance by investigators. The
frogs were maintained with husbandry conditions de-
scribed above. Corticosterone (CORT; Sigma) and me-
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tyrapone (MTP; Sigma) were first dissolved in ethanol and
added to the aquarium water to the appropriate final
concentrations. The vehicle ethanol was adjusted to a final
concentration of 0.0005% in all tanks, including the con-
trols. The CORT-treated group received 500 nM CORT in
the aquarium water for 4 days (treatment started on day
1, and frogs were killed on day 5). This dose of CORT
produced a stress level plasma CORT concentration (see
Results). The water was changed on day 3, and CORT was
added to the water daily. The whole-body CORT content in
Xenopus tadpoles, and the nominal concentration of CORT
in the aquarium water decrease to less than 10% of the
starting values by 24 hr following addition of the hormone
(Krain and Denver, 2004; data not shown), so we added
the hormone to the tanks without water change on days 2
and 4. This served to minimize disturbance to the animals.
The MTP-treated group was exposed to 110 M MTP for 5
days; treatment was started on day 1, and frogs were
killed on day 6. This dose of MTP was chosen because it
decreases CORT to undetectable levels in X. laevis but
does not cause overt toxicity (Glennemeier and Denver,
2002). MTP was added on day 1 and day 3 at the time of
water change. For the MTP  CORT treatment, frogs
were treated with 110 M MTP for 1 day, followed by MTP
plus a replacement dose of 50 nM CORT for 4 days. This
dose of CORT produced a plasma CORT concentration
similar to basal, unstressed levels in MTP-treated ani-
mals (see Results). The MTP and CORT were added to the
aquarium water in the same manner as the single-drug
treatments described above. All frogs were rapidly killed
between 1300 and 1500 hours by submersion in 0.05%
benzocaine, followed by decapitation, and tissues were
collected. Blood was collected and plasma separated for
CORT radioimmunoassay (see below). The heads were
fixed in cold 4% paraformaldehyde overnight. Brains were
dissected, postfixed in cold 4% paraformaldehyde for 1–2
hours, and submerged in 30% sucrose before snap freezing
and transverse cryosectioning at 10 m.
Shaking/handling stressor. Juvenile X. laevis were
subjected to a shaking/handling stressor as previously
described (Yao et al., 2004). Briefly, frogs were placed into
32-oz. white polypropylene containers, with two or three
frogs in 250 ml water. The containers were placed on an
orbital shaker and shaken continuously at 100 rpm for 6
hours. The frogs were killed by immersion in 0.05% ben-
zocaine, and blood was collected for CORT radioimmuno-
assay (RIA).
Plasma corticosterone RIA
CORT was measured in frog plasma by using methods
described by Licht et al. (1983). Briefly, plasma was ex-
tracted using diethyl ether, and the RIA was conducted
using a corticosterone antiserum purchased from MP Bio-
medicals (Orangeburg, NY). All samples were measured
in a single assay, and intraassay coefficient of variation
was 10%.
Morphometric analysis of GR
immunoreactivity
We quantified GR-ir in discrete brain regions using the
MetaMorph software package (v 6.2r4; Universal Imaging
Corp., Downingtown, PA). We processed all samples si-
multaneously under identical conditions. With the ana-
tomical definitions of Tuinhof et al. (1998) and Marı́n et al.
(1998; see Fig. 4), we selected for analysis three to five
coronal sections from each animal that contained the
POA, amygdala, and bed nucleus of the stria terminalis
(BNST) or medial pallium (mp); the number of sections
analyzed depended on the size of the brain region. These
brain regions were selected because of their strong GR-ir,
suggesting that they are important targets for GC actions,
and their known roles in the regulation of the HPA axis.
All sections were carefully matched for anatomical level,
and digital images were captured at 100 magnification
for morphometric analysis. Image analysis was conducted
in a blinded manner. We isolated brain regions on the
captured images with a hand-made frame that covered the
area of interest. Each selected brain region analyzed on
adjacent sections and from different brains was roughly
equivalent in total area, but, because each sample differed
slightly in shape, we drew boxes by hand around each
region of interest. Using the “Auto threshold for dark
objects” tool in the Metamorph software, we adjusted the
threshold to eliminate background staining. This was re-
peated on five to eight sections, and a mean threshold was
established that was then set for analysis of all sections.
The signal density within a selected area was then
counted automatically. The signal density was divided by
the total area of the selected brain region to obtain a mean
signal density, which allowed for correction for size differ-
ences between brains and between adjacent sections. The
average of the mean densities in a given brain region on
replicate brain sections was calculated, summed for all
animals in the treatment, then divided by the number of
animals in the treatment to obtain the average signal
density for each brain region (see Yao et al., 2004, 2007).
RNA extraction and real-time RT-
quantitative PCR analysis
We analyzed GR mRNA expression in microdissected
regions of the frog brain by RTqPCR as described previ-
ously (Yao et al., 2007). For the analysis of the distribution
of GR mRNA in the frog brain, we chose adult frogs be-
cause of their larger brains, which allowed for finer dis-
section of brain regions compared with juvenile frogs.
Because the adult frogs were sexually mature, we com-
pared males and females (n  5/sex).
To analyze the effects of corticosteroid manipulations on
GR mRNA, we dissected the telencephalon/preoptic region
from juvenile frogs treated with CORT or MTP as de-
scribed above. We isolated total RNA from individual tis-
sues using the Trizol reagent (Invitrogen). First-strand
cDNA was synthesized with SuperScript II Reverse Tran-
scriptase (Invitrogen) and random hexamers, following
the manufacturer’s instructions. We designed a gene-
specific Taqman primer/probe set for X. laevis GR that
spanned an intron/exon boundary: forward primer: 5-
CTGGCAGCGCTTTTACCAA-3, reverse primer: 5-AT-
TCTCAGCCACCTCATGCAT-3; probe: 6FAM-TGACAA-
AGCTATTGGACTC-MGQ. Reactions were run with the
Fast 7500 Real-Time PCR System (Applied Biosystems,
Foster City, CA), and we used a relative quantitation
method by generating a standard curve with a pool of
cDNA from the tissue with the highest level of expression
(the telencephalon). The GR mRNA expression level was
normalized to the expression of the X. laevis ribosomal
protein L8 mRNA as previously described (Yao et al.,
2007).
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Statistical analysis
We analyzed the data in Systat v10 statistical software
(SPSS Inc., Chicago, IL). Data were log10 transformed
before statistical analysis when the variances were found
to be heterogeneous (Bartlett’s test). Treatment effects on
mean GR-ir signal density, plasma corticosterone, or GR
mRNA were analyzed by one-way ANOVA followed by
Fisher’s least squares differences (LSD) multiple-
comparisons test. The data presented in the graphs are
the mean  SEM, and P  0.05 was considered statisti-
cally significant.
RESULTS
Production and verification of the
specificity of affinity-purified xGR
antiserum
We generated a polyclonal antiserum in rabbit against a
short peptide conjugated to keyhole limpet hemocyanin
that is located in the N-terminal region of xGR (amino acid
residues 8–25). To enhance the specificity of the reagent
we purified the antiserum by affinity chromatography (see
Materials and Methods). The specificity of the affinity-
purified xGR antibodies was first examined by Western
blotting with in vitro-expressed xGR. A single 35S-labeled
protein of the expected MW (96 kD) was produced by in
vitro synthesis (Fig. 1A). A protein of a similar MW was
recognized by Western blotting in the p6xGR pro-
grammed, but not in the unprogrammed TNT rabbit re-
ticulocyte lysate reaction (Fig. 1B). The two smaller-MW
bands observed in both lanes of the Western blot represent
the IgG heavy and light chains present in the rabbit
reticulocyte lysate and recognized by the goat anti-rabbit
secondary antibody.
We conducted immunocyctochemistry on A6 cells (X.
laevis kidney cells that express GR; Claire et al., 1989;
Watlington et al., 1982) using the same affinity-purified
antibody and found that GR-ir was in the cytoplasm and
nucleus of the cells (Fig. 2A). Preabsorption of the anti-
body with the antigenic xGR peptide greatly reduced im-
munostaining (Fig. 2B). Exposure to the GR agonist dexa-
methasone (DEX; 100 nM) for 1.5 hours caused the GR-ir
to concentrate in the nucleus (Fig. 2C,E, untreated; Fig.
2D,F, DEX treated). Exposure to CORT (100 nM) also
caused translocation of GR to the nucleus in A6 cells (data
not shown). The unique sequence of the antigenic xGR
peptide that we used for immunization, the results of the
analyses described above, taken together with the results
of our IHC analyses on frog brain (discussed below), sup-
port that our affinity-purified IgG specifically recognizes
frog GR.
Distribution of GR-ir in the brain and
pituitary of juvenile X. laevis
IHC analysis showed that GR-ir cells are widely distrib-
uted throughout the brain and pituitary of juvenile X.
laevis. Preabsorption of the anti-xGR IgG with the xGR
antigenic peptide eliminated the specific immunosignal in
the brain, whereas preabsorption with a mixture of three
unrelated peptides (corresponding to three regions of the
frog MR) did not alter the staining (Fig. 3). We observed
staining of the ependyma throughout the brain, which
may be artifactual insofar as it was not eliminated by
preabsorption (see Fig. 3B).
Discrete groups of GR-ir cells were seen in the telen-
cephalon, diencephalon, mesencephalon, and rhomben-
cephalon. In most GR-ir cells in the brain, the immunore-
activity was localized in both the nucleus and the
cytoplasm, and in some regions the immunostaining was
higher in the cytoplasm than in the nucleus. A schematic
representation of the distribution of GR-ir cells in the
brain and pituitary gland of X. laevis is shown in Figure 4.
The detailed distribution of GR-ir cells in the frog brain
and pituitary gland is described below.
Telencephalon. The most rostral sites of GR-ir were
found in small cells in the lateral pallium and internal
granule cell layer of the olfactory bulbs (Figs. 4A,B, 5A,B).
In the more caudal portions of the telencephalon, many
small GR-ir cells were localized in the dorsal pallium,
striatum, and lateral septum. Large GR-ir cells were
found in the medial pallium and accumbens (Figs. 4B,C,
5C,D). The immunoreactivity was seen in both the nucleus
and the cytoplasm in most of these GR-ir cells.
Diencephalon. Small GR-ir cells were seen in the lat-
eral, medial, and central amygdala and BNST (Figs. 4D,
5E,F) The highest density of GR-ir cells was localized in
both the parvocellular and the magnocellular divisions of
the POA. In rostral regions of the POA, immunostaining
was found mostly in the parvocellular cells in the periven-
Fig. 1. Affinity-purified antiserum to X. laevis GR recognizes full-
length xGR synthesized in vitro. A: A major product of 96 kD was
synthesized in the in vitro transcription/translation reaction using
the p6xGR plasmid as template. [35S]methionine  cysteine was
included in the in vitro transcription-translation reaction, and the
reaction was analyzed by 10% SDS-PAGE, followed by fluorography.
B: A protein of 96 kD was detected by Western blotting of the in
vitro transcription/translation reaction programmed with the p6xGR
vector but not in unprogrammed rabbit reticulocyte lysate. The arrow
indicates the xGR protein band. The two lower MW bands are the
rabbit IgG heavy and light chains present in the lysate and recognized
by the goat anti-rabbit secondary antibody.
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tricular zones of the third ventricle (Figs. 4D, 5G). We could
not determine whether the GR-ir was nuclear or cytosolic in
the parvocellular cells of the POA because of their small size
and relatively large nuclei. In more caudal regions of the
POA, strong GR-ir was observed in cells in the dorsal mag-
nocellular area (Figs. 4E, 5H). The GR-ir in these cells was
found in both the nucleus and the cytoplasm. Several scat-
tered, small GR-ir cells were seen in the hypothalamus and
thalamus, including the ventral habenlar, anterior thalamic,
ventromedial thalamic, ventrolateral thalamic, posterior
thalamic, and ventral hypothalamic nuclei (Figs. 4F,G, 5I).
Larger GR-ir cells were found in the suprachiasmatic nu-
cleus (Figs. 4F, 6A). The immunoreactivity was distributed
in both the nucleus and the cytoplasm in most of these
hypothalamic and thalamic GR-ir cells.
Mesencephalon. Well-organized, small GR-ir cells
were also seen in different layers of the optic tectum (Fig.
4H). High levels of GR-ir staining were found in the torus
semicircularis, posterior tuberculum regions, and tegmen-
tal nuclei (Figs. 4H, 6B). The immunoreactivity was found
in both the nucleus and the cytoplasm of these GR-ir cells.
Rhombencephalon. Small GR-ir cells were observed
in the locus coeruleus (Fig. 4I), and large cells were ob-
served in the cerebellum, especially in the Purkinje cell
layer (Fig. 4J; see also Fig. 6C). Small GR-ir cells were
found in the raphe nuclei, reticular nuclei, and nuclei of
the trigeminal motor nerves (Figs. 4J, 6D). The subcellu-
lar distribution of GR-ir in these cells was also both nu-
clear and cytoplasmic.
Pituitary. Dense GR-ir cells were found in rostral por-
tions of the pars distalis, where the corticotrope cells are
located (Fig. 4H, 6E; Campantico et al., 1985). These cells
exhibited very strong nuclear GR-ir. Fewer GR-ir cells were
seen in the caudal regions of the pars distalis. Weak GR-ir
signal was also seen in the pars intermedia layer (Fig. 4H),
but we did not identify the cell type (i.e., melanotrope vs.
folliculostellate). No GR-ir was observed in the pars nervosa
layer or in the median eminence.
Fig. 2. The affinity-purified anti-xGR IgG recognizes a protein in
A6 cells that shows nuclear translocation following treatment with
the GR agonist dexamethasone. A6 cells were fixed and immuno-
stained with anti-xGR IgG (A) or anti-xGR IgG preabsorbed with 50
g/ml of the antigenic xGR peptide (B; 20 magnification). xGR
immunoreactivity in A6 cells treated with (C,E) or without (D,F)
dexamethasone for 1.5 hours (100 nM). C and D are at 10 magnifi-
cation, and E and F are at 40 magnification. Scale bars  100 m in
A (applies to A,B); 100 m in C (applies to C,D); 100 m in E (applies
to E,F). [Color figure can be viewed in the online issue, which is
available at www.interscience.wiley.com.]
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Effects of manipulation of plasma
corticosteroids on GR-ir in the frog CNS
and pituitary gland
We first conducted an experiment to determine whether
the doses of CORT and MTP chosen caused changes in
plasma CORT concentrations in juvenile X. laevis that
were within the physiological range. We treated frogs with
vehicle (0.0005% ethanol; control), CORT (500 nM), MTP
(110 M), or MTP  CORT (50 nM) as described above.
Prior to sacrifice and blood collection, we divided the ve-
hicle controls into two groups and exposed one group to
shaking/confinement stressor for 6 hours (stressed),
whereas the other group (control) was left undisturbed.
Treatment with CORT (500 nM) for 4 days increased the
plasma CORT concentration to a level similar to that
achieved by exposure to shaking/confinement stressor (P 
0.001, ANOVA; Fig. 7; see also Yao et al., 2004). By contrast,
MTP treatment caused the plasma CORT concentration to
fall below the detection limit of the RIA (Fig. 7). Exposure to
MTP  CORT (50 nM) resulted in plasma CORT concentra-
tions that were not different from control (Fig. 7).
To determine whether circulating GCs can influence GR
expression, we analyzed the mean GR-ir signal density in
discrete regions of the brain and pituitary gland of juve-
nile frogs treated with CORT, MTP, or MTP  CORT. In
the POA, treatment with CORT decreased mean GR-ir
signal density to 20% of control (P  0.001, ANOVA,
Fisher’s LSD; Fig. 8B). Treatment with MTP also caused a
marked decrease in the mean GR-ir signal density in this
brain region to 60% of control (P  0.004, Fig. 8C), which
was reversed by cotreatment with a replacement dose (50
nM) of CORT (Fig. 8D).
As in the POA, treatment with CORT decreased mean
GR-ir signal density in the MeA (to 50% of control, P 
0.009), the BNST (to 60% of control, P  0.003), and the
mp (to 20% of control, P  0.001, Fig. 9). Treatment with
MTP also decreased GR-ir in these regions (MeA, to 30%
of control, P  0.001; BNST, to 56% of control, P  0.002;
mp, to 47% of control, P  0.001), which could be re-
versed by cotreatment with a replacement dose of CORT
(Fig. 9).
Similar to effects on the brain, treatment with CORT
strongly decreased GR-ir signal density in the rostral pars
distalis (to 28% of control, P  0.001; Fig. 9). By con-
trast, treatment with MTP alone or in combination with a
replacement dose of CORT did not alter GR-ir in the
pituitary gland (Fig. 9).
Distribution of GR mRNA in frog brain and
effects of corticosteroid manipulation
We detected GR mRNA expression by RTqPCR through-
out the adult frog brain (Fig. 10A). There were no signif-
icant differences between males and females in any brain
region; therefore, we pooled data from both sexes. We
found significant differences in GR mRNA expression in
different brain regions (P  0.001, ANOVA). Higher ex-
pression was observed in the forebrain region (telenceph-
alon and preoptic area) and lower expression in the spinal
cord.
Manipulation of circulating corticosteroids by CORT or
MTP treatment caused significant changes in GR mRNA
in the telencephalon/preoptic area (P  0.004). Similar to
GR-ir in this and other brain regions, GR mRNA levels
were decreased by CORT or MTP treatment by 30% and
35%, respectively, compared with the control (Fig. 10B).
Treatment with MTP plus a replacement dose of CORT
reversed the effects of MTP on GR mRNA.
DISCUSSION
Evolutionary conservation of GC targets in
the vertebrate brain and pituitary
Here we present the first detailed study in a nonmam-
malian tetrapod of the distribution of GR-ir in the brain
and pituitary gland and the regulation of GR by circulat-
ing corticosteroids. We found GR-ir cells distributed
throughout the brain, from the olfactory bulbs to the
brainstem. The wide distribution of GR-ir in the CNS is
consistent with findings in mammals, a bird, and several
teleost fishes; expression of GR in all regions of the frog
brain mentioned above has been reported for homologous
brain regions of the rat (Ahima and Harlan, 1990; Mori-
Fig. 3. The anti-xGR IgG specifically stains a subset of cells in the
X. laevis brain. Shown are photomicrographs of transverse sections
through the anterior preoptic area (POA) of a juvenile X. laevis.
Adjacent sections were immunostained with anti-xGR IgG (A), anti-
xGR IgG preabsorbed with 50 g/ml of the antigenic xGR peptide (B),
or anti-xGR IgG preabsorbed with 50 g/ml of a mixture of three
unrelated peptides that corresponded to regions of the frog MR (C).
All three images were captured at the same magnification. Scale
bar  120 m.
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Fig. 4. A–J: Schematic coronal illustration of glucocorticoid recep-
tor (GR) immunoreactivity (-ir) distribution in the brain of juvenile X.
laevis. The drawing at the top of the figure shows a dorsal view of the
X. laevis brain. Letters correspond to the rostrocaudal location of
sections as depicted in the whole-brain drawing. Large circles repre-
sent large cells that exhibited robust GR-ir, and small circles repre-
sent smaller GR-ir cells. The anatomical drawings are from Tuinhof et
al. (1998), with modifications of basal ganglia subdivisions according
to Marı́n et al. (1998).
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moto et al., 1996) and Japanese quail (Kovács et al., 1989),
and most of these structures in fishes (Carruth et al.,
2000; Teitsma et al., 1998). The strong GR-ir signal in
forebrain structures of the frog is consistent with our
RTqPCR analysis, which showed that GR mRNA levels
were highest in the forebrain (telencephalon and preoptic
area) compared with more caudal regions (e.g., the optic
tectum, hindbrain, and spinal cord). Our IHC analyses
were conducted on sexually immature juvenile frogs, and,
although we could not conduct a thorough analysis of
possible sex differences in GR expression, we found no
such differences in GR mRNA levels throughout the sex-
ually mature adult frog brain.
The GR is expressed in hypophysiotropic
brain nuclei and the pituitary gland
We found high GR-ir density in the parvocellular divi-
sion of the POA in the frog brain, similar to that observed
in the rat and in fishes (Carruth et al., 2000; Teitsma et
al., 1998). Cells in this region express a number of neu-
Fig. 5. Photomicrographs of transverse sections through the fore-
brain and part of the midbrain of juvenile X. laevis showing the
distribution of glucocorticoid receptor (GR)-immunoreactive (-ir) cells.
A: Internal granule cell layer of the olfactory bulb (igl). B: Dorsal
pallium (dp) and lateral pallium (lp). C: Nucleus accumbens (Acc) and
lateral septum (ls). D: Medial pallium (mp). E: Medial amygdala
(MeA). F: Bed nucleus of the stria terminalis (BNST). G: Anterior
preoptic area (POA). H: Posterior preoptic area (POA). I: Ventral
hypothalamic nucleus (VH). lv, Lateral ventricle, IIIv, third ventricle.
Scale bars  120 m.
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ropeptides, including CRF (Bidaud et al., 2004; Calle et
al., 2006; Daniello et al., 1996; DiMatteo et al., 1996;
González et al., 1995; Yao et al., 2004). GCs cause negative
feedback on neurosecretory CRF neurons in the frog sim-
ilar to that in mammals and fishes (Yao et al., 2008; for
review see Yao et al., 2007). The high expression of GR in
this region suggests that GCs exert direct actions on these
cells, which is further supported by our finding that CRF
and GR colocalize in cells of the frog POA (Yao et al.,
2008).
A significant difference between GR-ir distribution in
the frog and the bird and mammal is that we found a high
density of GR-ir in the magnocellular division of the frog
POA, whereas no GR-ir was detected in the magnocellular
division of the PVN in intact rat or Japanese quail (Kovács
et al., 1989). Cells in this region express urocortin I and
arginine vasotocin (Acher, 1996; Calle et al., 2005). Strong
GR-ir in these cells was also found in rainbow trout and
kokanee salmon (Carruth et al., 2000; Teitsma et al.,
1998). The finding of high basal GR expression in the
magnocellular POA in the frog and in fishes but not in the
homologous regions of a bird or mammals could be related
to the aquatic vs. terrestrial life histories of these species.
However, it is noteworthy that, although the rat has un-
detectable GR in the magnocellular PVN neurons in the
basal state, exposure to osmotic stress induced GR expres-
sion in AVP neurons located in this region (Berghorn et
al., 1995). Also, studies in transfected cells found direct
inhibition of AVP gene promoter activity by dexametha-
sone (Iwasaki et al., 1997).
We found strong GR-ir in cell nuclei of the frog rostral
pars distalis. A high density of GR-ir in this tissue was
Fig. 6. Photomicrographs of transverse sections through the mid-
brain, hindbrain, and pituitary gland of juvenile X. laevis showing the
distribution of glucocorticoid receptor (GR)-immunoreactive cells.
A: Suprachiasmatic nucleus (SC). B: Tegmental nuclei (Tn). C: Cer-
ebellum (Cb). D: Motor nucleus of the trigeminal nerve (Vm) and
raphe nucleus (Ra). E: Pars distalis of the anterior pituitary gland (pd
with arrow; ME, median eminence). Scale bars  120 m.
Fig. 7. Plasma corticosterone concentrations in X. laevis juveniles
following pharmacological treatments and exposure to shaking/
confinement stressor. Juvenile frogs were reared in water containing
vehicle (0.0005% ethanol; control and stressed) for 4 days, corticoste-
rone (CORT; 500 nM) for 4 days, metyrapone (MTP; 110 M) for 5
days, or MTP for 1 day followed by MTP  CORT (50 nM) for 4 days
(MTP CORT 50 nM). During the 4-day treatment period, all groups
were exposed to 0.0005% ethanol. The “stressed” group was exposed to
6 hours of shaking/confinement stressor before sacrifice; animals in
the other treatments were left undisturbed, and all animals were
killed in the afternoon of the same day. Data presented are the
mean  SEM. Significant differences from control are indicated (n 
5–6/treatment; *P  0.05, ANOVA).
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Fig. 8. Effects of changes in plasma corticosteroid concentration
on glucocorticoid receptor (GR) immunoreactivity (-ir) in the anterior
preoptic area (POA) of juvenile X. laevis. A: The photomicrographs are
of representative transverse sections in the same anatomical plane of
the POA; vehicle control (B; 0.0005% ethanol), corticosterone (C;
CORT; 500 nM for 4 days), metyrapone (D; MTP; 110 M for 5 days),
MTP  CORT (110 M MTP for 1 day followed by MTP  50 nM
CORT for 4 days). The graph shows the densitometric analysis of
GR-ir in the POA following hormone or drug treatments (treatments
as described above). Bars represent the mean  SEM. Significant
differences from the control are indicated (n  5–6/treatment, *P 
0.05; ANOVA). Scale bar  120 m.
also reported for mammals and fishes, and GCs are well
known to influence anterior pituitary hormone biosynthe-
sis and secretion (Ahima and Harlan, 1990; Carruth et al.,
2000; Herman et al., 2003; Kononen et al., 1993; Morimoto
et al., 1996; Ozawa et al., 1999; Teitsma et al., 1998). We
also found weak GR-ir staining in the intermediate lobe of
the frog pituitary gland. GR-ir was not detected in this
region of the pituitary of intact rat or rainbow trout,
although GR mRNA and GC binding activity have been
reported here in rat (Ahima and Harlan, 1990; Morimoto
et al., 1996; Ozawa et al., 1999; Sheppard et al., 1993;
Teitsma et al., 1998). In X. laevis, the neurointermediate
lobe expresses proopiomelanocortin (POMC), which is pro-
cessed to 	-melanocyte-stimulating hormone (	MSH);
	MSH plays an important role in background adaptation
in the frog (Dotman et al., 1996; Loh et al., 1985; Tuinhof
et al., 1998). The expression of GR suggests that POMC
gene expression, and thus 	MSH, could be subject to reg-
ulation by circulating GCs. Our finding that GR-ir is not
present in the posterior pituitary (neural lobe) of the frog
is in agreement with studies in rainbow trout (Teitsma et
al., 1998), although GR-ir has been found in the rat neural
lobe (Kononen et al., 1993; Ozawa et al., 1999).
Expression of GR in the frog limbic system
suggests a phylogenetically ancient role for
these structures in regulation of the HPA
axis
We observed high GR-ir density in limbic structures of
the frog brain. The expression of GR mRNA and protein in
limbic structures is well documented in mammals (Ahima
and Harlan, 1990; Morimoto et al., 1996). In the mamma-
lian hippocampus, the CA1 and CA2 pyramidal cell layers
and the dentate gyrus all express high levels of GR mRNA
and GR-ir (Ahima and Harlan, 1990; Morimoto et al.,
1996). Strong expression of GR mRNA and immunoreac-
tivity were also seen in all subfields of the amygdala and
BNST (Ahima and Harlan, 1990; Morimoto et al., 1996).
The amphibian and fish homologs of the mammalian
hippocampus (medial pallium) are much less differenti-
ated compared with mammals. Also, although the sub-
fields of the amygdala are biochemically distinct in frogs
and fishes, they are more difficult to distinguish morpho-
logically than those of mammals. Nonetheless, we ob-
served dense GR-ir cells in the frog mp, the MeA, and the
BNST. Similar GR distribution was observed in fishes
Fig. 9. Effects of changes in plasma corticosteroid concentration
on glucocorticoid receptor (GR) immunoreactivity (-ir) in the medial
amygdala, bed nucleus of the stria terminalis (BNST), medial pal-
lium, and rostral pars distalis of the anterior pituitary of juvenile X.
laevis. Treatments are described in the legend to Figure 8. Bars
represent the mean GR-ir density (see Materials and Methods) 
SEM. Significant differences from the control are indicated (n 
5–6/treatment; *P  0.05, ANOVA).
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(Carruth et al., 2000; Teitsma et al., 1998). The only study
to our knowledge on GR-ir distribution in the bird brain
did not find it in the hippocampus or the archistriatum,
whereas GR-ir was observed in the lateral septum (Kovács
et al., 1989). The investigators did not report whether they
found GR-ir in other limbic structures (e.g., the amygdala
or BNST) in the bird brain. Conserved patterns of GR
expression in limbic structures in fishes, frog, and mam-
mals suggest that the regulation of these regions by GCs
may be phylogenetically ancient and evolutionarily con-
served. GCs can negatively regulate the activity of PVN
CRF neurons in mammals indirectly via a descending
inhibitory pathway originating in the hippocampus (for
review see Yao et al., 2007). By contrast, GCs induced
CRF expression in the amygdala and BNST of mammals
(Makino et al., 1994) and the frog (Yao et al., 2008). Our
findings of GR expression in the homologous regions of the
frog brain suggest that these structures could play similar
roles (e.g., cognition, fear responses) and that GCs influ-
ence their structure and function in frogs as they do in
mammals.
GCs regulate GR expression in the frog
brain
Autoregulation of GR expression by GCs has been de-
scribed in mammals, and we found similar actions in the
frog, suggesting that this mode of regulation is phyloge-
netically ancient. Treatment with CORT decreased GR-ir
in the POA, MeA, BNST, mp, and anterior pituitary of the
frog. CORT treatment also decreased GR mRNA in the
frog telencephalon/preoptic area. In the rat, administra-
tion of GCs for days to weeks decreased GR protein and
mRNA throughout the brain (Chao et al., 1998; Ghosh et
al., 2000; Han et al., 2007; Holmes et al., 1995; Hügin-
Flores et al., 2004; Reul et al., 1989; Sapolsky et al., 1984;
Spencer et al., 2000). In tissue culture studies, GCs de-
creased expression of GR mRNA and protein or activity of
the GR gene promoter in transfected cells (Bellingham et
al., 1992; Burnstein et al., 1991; Dong et al., 1988; Meyer
and Schmidt, 1995; Okret et al., 1986; Silva et al., 1994;
Vedeckis et al., 1989). Different mechanisms for the down-
regulation of GR expression by GCs have been proposed,
including inhibition of transcription (Dong et al., 1988;
Okret et al., 1991; Rosewicz et al., 1988), posttranscrip-
tional regulation (decreased mRNA stability or translat-
ability; Burnstein et al., 1991; Meyer and Schmidt, 1995;
Okret et al., 1986; Vedeckis et al., 1989), and posttrans-
lational regulation (decreased protein stability and/or in-
creased protein degradation; Dong et al., 1988; Okret et
al., 1991; Webster et al., 1997).
If GCs negatively regulate GR expression, then one
would predict that their removal by surgical or chemical
adrenalectomy would elevate GR expression. Such an ef-
fect has been reported in rats, where short-term adrenal-
ectomy (1–5 days) increased total GR protein in the hip-
pocampus, hypothalamus/PVN, and cortex as measured
by Western blotting (Kalman and Spencer, 2002;
O’donnell et al., 1995; Spencer et al., 2000). Short-term
(within 1 week) adrenalectomy also increased GR mRNA
in the hippocampus, which was reversed by GC supple-
mentation, whereas GR mRNA in the PVN was increased
or unaffected by short-term adrenalectomy (Chao et al.,
1998; Han et al., 2007; Holmes et al., 1995; Hügin-Flores
et al., 2004; Reul et al., 1989).
However, we found in the frog that treatment with the
corticosteroid synthesis inhibitor MTP for 5 days de-
creased GR-ir in POA, MeA, BNST, and mp. The decrease
caused by MTP was reversed by cotreatment with a re-
placement dose of CORT. The changes in GR-ir in the
brain with MTP were paralleled by changes in GR mRNA.
The GR-ir in the anterior pituitary was unaffected by
MTP, which suggests that the regulation of GR expression
is cell type dependent and also argues against a nonspe-
cific toxicity of the MTP. In the rat, by contrast to the
short-term (1 week) effects of ADX (discussed above), 1
week of ADX produced a marked decrease in GR-ir in
several brain areas (Hu et al., 1997b; Rosenfeld et al.,
1988; Visser et al., 1996), and longer-term ADX (1 week)
Fig. 10. Expression of GR mRNA in frog brain as analyzed by
real-time quantitative PCR (RTqPCR). A: Distribution of GR mRNA
in adult frog brain. Brain regions were microdissected from five male
and five female adult X. laevis. There were no sex differences in GR
mRNA expression, so we pooled the data (n  8–10 per brain region).
B: Effects of manipulation of circulating corticosteroids on mRNA
expression in the telencephalon/preoptic area of juvenile X. laevis.
Frogs were treated as described in the legend to Figure 8. Total RNA
was extracted and gene expression analyzed by RTqPCR. A relative
quantitation method was used, and GR mRNA was normalized to the
expression of the housekeeping gene rpL8; therefore, the data are
presented as arbitrary units. Bars represent the mean  SEM. Let-
ters indicate significant differences among brain regions or treatment
groups (P  0.05, Fisher’s LSD multiple-comparisons test).
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resulted in the loss of detectable GR-ir throughout the
brain (Han et al., 2005; Hu et al., 1997a; Visser et al.,
1996). Taken together, our findings in the frog and those
in the rat suggest that, although elevated GCs can nega-
tively regulate GR expression, a basal GC level may be
required for maintaining GR expression over the longer
term.
Autoregulation of GR by circulating GCs is hypothe-
sized to be an important mechanism for regulating the
responsiveness of the HPA axis during chronic stress. In
rats exposed to repeated or chronic stressors, GR mRNA
expression was down-regulated in the hippocampus, front-
parietal cortex, PVN, and LC (Gomez et al., 1996; Herman
et al., 1995; Makino et al., 1995, 2002b; Nishimura et al.,
2004). Decreases in GR expression in these brain regions
during chronic stress may indicate a reduced inhibition of
the HPA activity by elevated circulating GCs, which could
contribute to maintaining the sensitivity of the tissue to
GCs and sustaining the responsiveness of the HPA axis to
further stimulation (Makino et al., 1995, 2002a).
In conclusion, our results support the idea that the
general patterns of GR expression in the CNS and pitu-
itary gland are highly conserved among vertebrates. Thus
GR is likely to play roles in mediating the actions of
corticosteroids on the frog brain similar to those in mam-
mals, suggesting that the basic regulatory pathways of the
neuroendocrine stress axis arose early in vertebrate evo-
lution and have been maintained by natural selection.
Expression of GR-ir in the frog brain areas involved in the
stress response (POA, mp, MeA, BNST) and the anterior
pituitary is regulated by circulating corticosteroids. These
findings suggest that autoregulation of GR in specific
brain regions and pituitary may be an evolutionarily con-
served mechanism for modulating the responsiveness of
the stress axis in vertebrates.
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González A, Muñoza A, Muñoza M, Marı́na O, Smeets WJAJ. 1995. On-
togeny of vasotocinergic and mesotocinergic systems in the brain of the
South African clawed frog Xenopus laevis J Chem Neuroanat 9:27–40.
Han F, Ozawa H, Matsuda K, Nishi M, Kawata M. 2005. Colocalization of
mineralocorticoid receptor and glucocorticoid receptor in the hippocam-
pus and hypothalamus. Neurosci Res 51:371–381.
Han F, Ozawa H, Matsuda KI, Lu H, De Kloet ER, Kawata M. 2007.
Changes in the expression of corticotrophin-releasing hormone, miner-
alocorticoid receptor and glucocorticoid receptor mRNAs in the hypo-
thalamic paraventricular nucleus induced by fornix transection and
adrenalectomy. J Neuroendocrinol 19:229–238.
Herman JP, Adams D, Prewitt C. 1995. Regulatory changes in neuroen-
docrine stress integrative circuitry produced by a variable stress par-
adigm. Neuroendocrinology 61:180–190.
Herman JP, Figueiredo H, Mueller NK, Ulrich-Lai Y, Ostrander MM, Choi
DC, Cullinan WE. 2003. Central mechanisms of stress integration:
hierarchical circuitry controlling hypothalamo-pituitary-adrenocortical
responsiveness. Front Neuroendocrinol 24:151–180.
Herman JP, Ostrander MM, Mueller NK, Figueiredo H. 2005. Limbic
system mechanisms of stress regulation: hypothalamo-pituitary-
adrenocortical axis. Prog Neuropsychopharmacol Biol Psychiatry 29:
1201–1213.
Hodgson ZG, Meddle SL, Roberts ML, Buchanan KL, Evans MR, Metzdorf
R, Gahr M, Healy SD. 2007. Spatial ability is impaired and hippocam-
pal mineralocorticoid receptor mRNA expression reduced in zebra
finches (Taeniopygia guttata) selected for acute high corticosterone
response to stress. Proc Biol Sci 274:239–245.
Holmes MC, Yau JLW, French KL, Seckl JR. 1995. The effect of adrenal-
ectomy on 5-hydroxytryptamine and corticosteroid receptor subtype
messenger-RNA expression in rat hippocampus. Neuroscience 64:327–
337.
Hu ZT, Yuri K, Morimoto M, Ozawa H, Kawata M. 1997a. Chronic loss of
glucocorticoids following adrenalectomy down-regulates the expression
of glucocorticoid receptor mRNA in the rat forebrain. Eur J Neurosci
9:1778–1783.
Hu ZT, Yuri K, Ozawa H, Lu HP, Yang YM, Ito T, Kawata M. 1997b.
Adrenalectomy-induced granule cell death is predicated on the disap-
pearance of glucocorticoid receptor immunoreactivity in the rat hip-
pocampal granule cell layer. Brain Res 778:293–301.
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